Kasumi Murai

2.3k total citations · 1 hit paper
19 papers, 1.5k citations indexed

About

Kasumi Murai is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Kasumi Murai has authored 19 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Hematology. Recurrent topics in Kasumi Murai's work include Epigenetics and DNA Methylation (5 papers), Muscle Physiology and Disorders (3 papers) and Cancer Cells and Metastasis (3 papers). Kasumi Murai is often cited by papers focused on Epigenetics and DNA Methylation (5 papers), Muscle Physiology and Disorders (3 papers) and Cancer Cells and Metastasis (3 papers). Kasumi Murai collaborates with scholars based in United Kingdom, Japan and Spain. Kasumi Murai's co-authors include Philip H. Jones, Yusuke Kamachi, Hisato Kondoh, Ryohei Sekido, Joanna C. Fowler, Agnieszka Wabik, Michael Hall, Alex Cagan, Peter J. Campbell and Krishnaa T. Mahbubani and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kasumi Murai

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Somatic mutant clones colonize the human esophagus with age

2018 651 citations Iñigo Martincorena, Joanna C. Fowler et al. Science profile →

Peers

Countries citing papers authored by Kasumi Murai

Since Specialization

Citations

This map shows the geographic impact of Kasumi Murai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kasumi Murai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kasumi Murai more than expected).

Fields of papers citing papers by Kasumi Murai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kasumi Murai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kasumi Murai. The network helps show where Kasumi Murai may publish in the future.

Co-authorship network of co-authors of Kasumi Murai

This figure shows the co-authorship network connecting the top 25 collaborators of Kasumi Murai. A scholar is included among the top collaborators of Kasumi Murai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kasumi Murai. Kasumi Murai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Organismal metabolism regulates the expansion of oncogenic PIK3CA mutant clones in normal esophagus 2024 ·Nature Genetics ·Albert Herms, Bartomeu Colom, Gabriel Piedrafita, (unknown), (unknown), Charlotte King, Emilie Abby, Kasumi Murai, (unknown), David Fernández‐Antorán, Swee Hoe Ong, Michael Hall, Chris Bryant, Roshan Sood, Joanna C. Fowler, Albert Pol, Christian Frezza, Bart Vanhaesebroeck, Philip H. Jones	4
2	p53 mutation in normal esophagus promotes multiple stages of carcinogenesis but is constrained by clonal competition 2022 ·Nature Communications ·Kasumi Murai, Stefan C. Dentro, Swee Hoe Ong, Roshan Sood, David Fernández‐Antorán, Albert Herms, Vasiliki Kostiou, Irina Abnizova, Benjamin A. Hall, Moritz Gerstung, Philip H. Jones	25
3	A single-progenitor model as the unifying paradigm of epidermal and esophageal epithelial maintenance in mice 2020 ·Nature Communications ·Gabriel Piedrafita, Vasiliki Kostiou, Agnieszka Wabik, Bartomeu Colom, David Fernández‐Antorán, Albert Herms, Kasumi Murai, Benjamin A. Hall, Philip H. Jones	62
4	Outcompeting p53-Mutant Cells in the Normal Esophagus by Redox Manipulation 2019 ·Cell stem cell ·David Fernández‐Antorán, Gabriel Piedrafita, Kasumi Murai, Swee Hoe Ong, Albert Herms, Christian Frezza, Philip H. Jones	77
5	Somatic mutant clones colonize the human esophagus with age breakdown → 2018 ·Science ·Iñigo Martincorena, Joanna C. Fowler, Agnieszka Wabik, Andrew Lawson, Federico Abascal, Michael Hall, Alex Cagan, Kasumi Murai, Krishnaa T. Mahbubani, Michael R. Stratton, Rebecca C. Fitzgerald, Penny A. Handford, Peter J. Campbell, Kourosh Saeb‐Parsy, Philip H. Jones	651
6	Epidermal Tissue Adapts to Restrain Progenitors Carrying Clonal p53 Mutations 2018 ·Cell stem cell ·Kasumi Murai, (unknown), Gabriel Piedrafita, Michael Hall, Vasiliki Kostiou, Swee Hoe Ong, Tibor Nagy, Alex Cagan, David Goulding, Allon M. Klein, Benjamin A. Hall, Philip H. Jones	60
7	Human keratinocytes have two interconvertible modes of proliferation 2015 ·Nature Cell Biology ·Amit Roshan, Kasumi Murai, Joanna C. Fowler, Benjamin D. Simons, (unknown), Philip H. Jones	70
8	HES6 enhances the motility of alveolar rhabdomyosarcoma cells 2012 ·Experimental Cell Research ·(unknown), Renae Domaschenz, (unknown), Daniel Williamson, Edoardo Missiaglia, Janet Shipley, Kasumi Murai, Philip H. Jones	7
9	Hes6 is required for actin cytoskeletal organization in differentiating C2C12 myoblasts 2011 ·Experimental Cell Research ·Caroline Malone, Renae Domaschenz, (unknown), Ian Dunham, Kasumi Murai, Philip H. Jones	11
10	Hes6 Is Required for the Neurogenic Activity of Neurogenin and NeuroD 2011 ·PLoS ONE ·Kasumi Murai, Anna Philpott, Philip H. Jones	15
11	Role for Amplification and Expression of Glypican-5 in Rhabdomyosarcoma 2007 ·Cancer Research ·Daniel Williamson, Joanna Selfe, Tony Gordon, Yong‐Jie Lu, Kathy Pritchard‐Jones, Kasumi Murai, Philip H. Jones, Paul Workman, Janet Shipley	77
12	Hes6 is required for MyoD induction during gastrulation 2007 ·Developmental Biology ·Kasumi Murai, Ann E. Vernon, Anna Philpott, Philip H. Jones	14
13	Characterization of a Megakaryocyte-specific Enhancer of the Key Hemopoietic Transcription Factor GATA1 2006 ·Journal of Biological Chemistry ·Boris Guyot, Kasumi Murai, (unknown), (unknown), (unknown), Sara Wells, Neil Dear, (unknown), Catherine Porcher, Paresh Vyas	16
14	Interaction of Serum Response Factor (SRF) with the Elk-1 B Box Inhibits RhoA-Actin Signaling to SRF and Potentiates Transcriptional Activation by Elk-1 2002 ·Molecular and Cellular Biology ·Kasumi Murai, Richard Treisman	47
15	Myeloid-specific transcriptional activation by murine myeloid zinc-finger protein 2 1998 ·Proceedings of the National Academy of Sciences ·Kasumi Murai, Hiroshi Murakami, Shigekazu Nagata	44
16	A novel form of the myeloid‐specific zinc finger protein (MZF‐2) 1997 ·Genes to Cells ·Kasumi Murai, Hiroshi Murakami, Shigekazu Nagata	19
17	Two mechanisms in the action of repressor δEF1: binding site competition with an activator and active repression 1997 ·Genes to Cells ·Ryohei Sekido, Kasumi Murai, Yusuke Kamachi, Hisato Kondoh	61
18	The δ-Crystallin Enhancer-Binding Protein δEF1 Is a Repressor of E2-Box-Mediated Gene Activation 1994 ·Molecular and Cellular Biology ·Ryohei Sekido, Kasumi Murai, J. Funahashi, Yusuke Kamachi, Atsuko Fujisawa‐Sehara, Yo-ichi Nabeshima, Hisato Kondoh	51
19	δ-crystallin enhancer binding protein δEF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis 1993 ·Development ·Jun-ichi Funahashi, Ryohei Sekido, Kasumi Murai, Yusuke Kamachi, Hisato Kondoh	193

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact